Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ronald Vance Mcintosh"'
Autor:
Peter R. Foster, Ronald Vance Mcintosh
Publikováno v:
Annals of Blood. 3:24-24
In his articles on the history of the development of Factor VIII concentrates (1,2), Albert Farrugia referred to our work at the Protein Fractionation Centre (PFC) of the Scottish National Blood Transfusion Service. We would like to provide some addi
Autor:
Robert A. Somerville, Peter R. Foster, Brenda Doreen Griffin, H E Reichl, Ian MacGregor, Phillip J. Steele, Ronald Vance Mcintosh, C. Bienek
Publikováno v:
Vox Sanguinis. 86:92-99
Background and Objectives The risk of haemophiliacs contracting variant Creutzfeldt-Jakob disease (vCJD) via treatment with factor VIII concentrates is not known. Therefore, in order to determine the extent to which the vCJD agent might be removed du
Autor:
Ronald Vance Mcintosh, Peter R. Foster
Publikováno v:
Transfusion Science. 11:55-66
Autor:
Ronald Vance Mcintosh, Peter R. Foster
Publikováno v:
Transfusion. 32:291-291
Autor:
Peter R. Foster, Ronald Vance Mcintosh
Publikováno v:
Separations for Biotechnology 2 ISBN: 9789401068390
The transmission of viruses such as HIV-1 has made the inactivation of viral contaminants a major development area in the manufacture of pharmaceutical proteins from human blood plasma. The risk of infection from biological materials is also an impor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b2572d6b6c8acba283427010305bc65
https://doi.org/10.1007/978-94-009-0783-6_53
https://doi.org/10.1007/978-94-009-0783-6_53
Publikováno v:
BMJ. 311:754-755
EDITOR,--In her editorial on hepatitis C and haemophilia Christine A Lee states that recombinant factor VIII “cannot transmit bloodborne viruses.”1 Although this belief is widely held, it is not correct. All biological substances can harbour infe
Autor:
Peter R. Foster, Ronald Vance Mcintosh
Publikováno v:
Transfusion. 31:573-574